Malnutrition and Dialysis

  • Denis Fouque
  • Joel D. Kopple


Several studies indicate that in patients undergoing maintenance hemodialysis (MHD) or chronic peritoneal dialysis (CPD), a low dietary protein intake as well as biochemical markers of protein or calorie malnutrition are associated with increased morbidity and mortality. MHD patients with low serum urea nitrogen (SUN) levels or decreased protein nitrogen appearance (also referred to as PCR) have increased morbidity or mortality (1, 2). Since in MHD patients, low SUN is associated with low dietary protein intake, these data suggest that decreased dietary protein intake is a risk factor for mortality. In 98 non-diabetic MHD patients followed for 12 months, an inverse relationship has been observed between the protein nitrogen appearance and the frequency of hospitalizations and mortality rate (2). In 1990, Lowrie and Lew showed that, in over 12,000 MHD patients followed for 12 months, of various predialysis serum chemistries, the serum albumin exhibited the most striking odds ratio for survival (3). The odds ratio for mortality rose exponentially as serum albumin fell.


Peritoneal Dialysis Chronic Renal Failure Hemodialysis Patient Dietary Protein Intake Chronic Peritoneal Dial 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Shapiro JI, Argy WP, Rakowski TA, Chester A, Siemsen AS, Schreiner GE: The unsuitability of BUN as a criterion for prescription dialysis. Trans Am Soc Artif Intern Organs 29: 129, 1983PubMedGoogle Scholar
  2. 2.
    Acchiardo SR, Moore LW, Latour PA: Malnutrition as the main factor in morbidity and mortality of hemodialysis patients. Kidney Int 24: 199, 1983Google Scholar
  3. 3.
    Lowrie EG, Lew LN: Death risk in hemodialysis patients: the predictive value of commonly measured variables and an evaluation of death rate differences between facilities. Am J Kidney Dis 5: 458, 1990Google Scholar
  4. 4.
    Churchill DN, Taylor DW, Cook RJ et al.: Canadian hemodialysis morbidity study. Am J Kidney Dis 3: 214, 1992Google Scholar
  5. 5.
    Owen WF, Lew NL, Liu Y, Lowrie EG, Lazarus JM: The urea reduction ratio and serum albumin concentrations as predictors of mortality in patients undergoing hemodialysis. N Engl J Med 329: 1001, 1993PubMedGoogle Scholar
  6. 6.
    Collins AJ, Ma JZ, Umen A, Keshaviah P: Urea index (Kt/V) and other predictors of hemodialysis patient survival. Am J Kidney Dis 23: 272, 1994PubMedGoogle Scholar
  7. 7.
    Teehan BP, Schleifer CR, Brown JM, Sigler ME, Raimondo J: Urea kinetic analysis and clinical outcome on CAPD. A five year longitudinal study. Adv Perit Dial 6: 181, 1990PubMedGoogle Scholar
  8. 8.
    Blake PG, Flowerdew G, Blake RM, Oreopoulos DG: Serum albumin in patients on continuous ambulatory peritoneal dialysis — predictors and correlations with outcomes. J Am Soc Nephrol 3: 1501, 1993PubMedGoogle Scholar
  9. 9.
    Rocco MV, Jordan JR, Burkart JM: The efficacy number as a predictor of morbidity and mortality in peritoneal dialysis patients. J Am Soc Nephrol 4: 1184, 1993PubMedGoogle Scholar
  10. 10.
    Keshaviah P, Churchill DN, Thorpe K, Taylor DW: Impact of nutrition on CAPD mortality. (Abstract) J Am Soc Nephrol 5: 494, 1994Google Scholar
  11. 11.
    Attman PO, Ewald J, Isaksson B: Body composition during long-term treatment of uremia with amino acid supplementation low-protein diet. Am J Clin Nutr 33: 801. 1980PubMedGoogle Scholar
  12. 12.
    Bianchi R, Mariani G, Toni MG, Carmassi F: The metabolism of human serum albumin in renal failure on conservative and dialysis therapy. Am J Clin Nutr 31: 1615, 1978PubMedGoogle Scholar
  13. 13.
    Heide B, Pierratos A, Khanna R et al.: Nutritional status of patients undergoing continuous ambulatory peritoneal dialysis (CAPD). Perit Dial Bull 3: 138, 1983Google Scholar
  14. 14.
    Kluthe R, Luttgren FM, Capetianu T, Heinze V, Katz N, Sudhoff A: Protein requirements in maintenance hemodialysis. Am J Clin Nutr 31: 1812, 1978PubMedGoogle Scholar
  15. 15.
    Kopple JD: Abnormal amino acid and protein metabolism in uremia. Kidney Int 14: 340, 1978PubMedGoogle Scholar
  16. 16.
    Salusky IB, Fine RN, Nelson P, Blumenkrantz MJ, Kopple JD: Nutritional status of children undergoing continuous ambulatory peritoneal dialysis. Am J Clin Nutr 38: 599, 1983PubMedGoogle Scholar
  17. 17.
    Thunberg BJ, Swamy AP, Cestero RV: Cross sectional and longitudinal nutritional measurements in maintenance hemodialysis patients. Am J Clin Nutr 34: 2005, 1981PubMedGoogle Scholar
  18. 18.
    Wolfson M, Strong CJ, Minturn D, Gray DR. Kopple JD: Nutritional status and lymphocyte function in maintenance hemodialysis patients. Am J Clin Nutr 39: 547. 1984PubMedGoogle Scholar
  19. 19.
    Young GA, Kopple JD, Lindholm B et al.: Nutritional assessment of continuous ambulatory peritoneal dialysis patients: an international study. Am J Kidney Dis 17: 462, 1991PubMedGoogle Scholar
  20. 20.
    Cano N, Fernandez JP, Lacombe P et al.: Statistical selection of nutritional parameters in hemodialysed patients. Proceedings of the fourth international congress on nutrition and metabolism in renal disease. Kidney Int 32(Suppl 22): S178, 1987Google Scholar
  21. 21.
    Young GA, Swanepoel CR, Croft MR, Hobson SM, Parsons FM: Anthropometry and plasma valine, amino acids, and proteins in the nutritional assessment of hemodialysis patients. Kidney Int 21: 492, 1982PubMedGoogle Scholar
  22. 22.
    Blumenkrantz MJ, Kopple JD, Gutman YK: Methods for assessing nutritional status of patients with chronic renal failure. Am J Clin Nutr 33: 1567, 1980PubMedGoogle Scholar
  23. 23.
    Schilling H, Wu G, Pettit J et al.: Nutritional status of patients on long-term CAPD. Perit Dial Bull 5: 12, 1985Google Scholar
  24. 24.
    Kopple JD, Chumlea WC, Gassman JJ et al.: Relationship between GFR and nutritional status — results from the MDRD study. (Abstract) J Am Soc Nephrol 5: 335, 1994Google Scholar
  25. 25.
    Bellinghieri G, Savica V, Mallamace A et al.: Correlation between increased serum and tissue L-carnitine levels and improved muscle symptoms in hemodialyzed patients. Am J Clin Nutr 38: 523, 1983PubMedGoogle Scholar
  26. 26.
    Delano BG, Manis JG, Manis T: Iron absorption in experimental uremia. Nephron 19: 26, 1977PubMedGoogle Scholar
  27. 27.
    Kopple JD, Swenseid ME: Vitamin nutrition in patients undergoing maintenance hemodialysis. Kidney Int 7(Suppl 2): S79, 1975Google Scholar
  28. 28.
    Lawson DH, Boddy K, King PC, Linton AL, Will G: Iron metabolism in patients with chronic renal failure on regular dialysis treatment. Clin Sci 41: 345, 1971PubMedGoogle Scholar
  29. 29.
    Mackenzie JC, Ford JE, Waters AH, Harding N, Cattell WR, Anderson BB: Erythropoiesis in patients undergoing regular dialysis treatment (RDT) without transfusion. Proc Eur Dialysis Transplant Assoc 5: 172, 1968Google Scholar
  30. 30.
    Mahajan SK, Prasad AS, Lambujon J, Abbasi AA, Briggs WA, McDonald FO: Improvement of uremic hypogeusia by zinc. A double-blind study. Am J Clin Nutr 33: 1517, 1980PubMedGoogle Scholar
  31. 31.
    Sprenger KBG, Bundschu D, Lewis K, Spohn B, Schmitz J, Franz H: Improvement of uremic neuropathy and hypogeusia by dialysate zinc supplementation: a double-blind study. Kidney Int 24(Suppl 16): S315, 1983Google Scholar
  32. 32. Consensus paper, chaired by Lasagna L and Schreiner G: Role of L-carnitine in treating renal dialysis patients. Dial and Transplant 23: 177, 1994Google Scholar
  33. 33.
    Carlson DM, Duncan DA, Naessens JM, Johnson WJ: Hospitalization in dialysis patients. Mayo Clin Proc 59: 769, 1984PubMedGoogle Scholar
  34. 34.
    Evans RW, Manninen DL, Garrison LP Jr et al.: The quality of life of patients with end-stage renal disease. N Engl J Med 312: 553, 1985PubMedCrossRefGoogle Scholar
  35. 35.
    Grodstein GP, Blumenkrantz MJ, Kopple JD: Nutritional and metabolic response to catabolic stress in chronic uremia. Am J Clin Nutr 33: 1411, 1980PubMedGoogle Scholar
  36. 36.
    Bergstrom J: Nutrition and adequacy of dialysis in hemodialysis patients. Kidney Int 43(Suppl 41): S261, 1993Google Scholar
  37. 37.
    Fouque D, Joly MO, Laville M et al.: Increase of serum Insulin-Like Growth Factor I (IGF 1) during chronic renal failure is reduced by low-protein diet. Miner Electrolyte Metab 18: 276, 1992PubMedGoogle Scholar
  38. 38.
    Ciancaruso B, Capuano A, D’amaro E et al.: Dietary compliance to a low protein and phosphate diet in patients with chronic renal failure. Kidney Int 36(Suppl 27): S173, 1989Google Scholar
  39. 39.
    Jacob V, Le Carpentier JE, Salzano S et al.: IGF-1, a marker of undernutrition in hemodialysis patients. Am J Clin Nutr52: 39, 1990PubMedGoogle Scholar
  40. 40.
    Eknoyan G. Beck GJ. Breyer JA etal.: Design and preliminary results of the mortality and morbidity of hemodialysis (MMHD) pilot study. (Abstract) J Am Soc Nephrol 5: 513, 1994Google Scholar
  41. 41.
    Bergstrom J, Mamoun H, Anderstam B, Sodersten P: Middle molecules (MM) isolated from uremic ultrafiltrate (UF) and normal urine induce dose-dependent inhibition of appetite in the rat. (Abstract) J Am Soc Nephrol 5: 488, 1994Google Scholar
  42. 42.
    Lindsay RM, Spanner E: A hypothesis: the protein catabolic rate is dependent upon the type and amount of treatment in dialyzed uremic patients. Am J Kidney Dis 13: 382, 1989PubMedGoogle Scholar
  43. 43.
    Bergstrom J, Alvestrand A, Lindholm B, Tranaeus A: Relationship between Kt/V and protein catabolic rate (PCR) is different in continuous peritoneal dialysis (CPD) and haemodialysis (HD) patients. (Abstract) J Am Soc Nephrol 2: 358, 1991Google Scholar
  44. 44.
    Borah M, Schoenfeld PY, Gotch FA, Sargent JA, Wolfson M, Humphreys MH: Nitrogen balance in intermittent hemodialysis therapy. Kidney Int 14: 497, 1978Google Scholar
  45. 45.
    Guttierez A, Alvestrand A, Wahren J, Bergstrom J: Effect of in vivo contact between blood and dialysis membranes on protein catabolism in humans. Kidney Int 38: 487, 1990Google Scholar
  46. 46.
    Lim VS, Bier DM, Flanigan MJ, Sum-Ping ST: The effect of hemodialysis on protein metabolism. A leucine kinetic study. J Clin Invest 91: 2429, 1993PubMedCrossRefGoogle Scholar
  47. 47.
    Giordano C, DePascale C, De Cristofaro D et al.: Protein malnutrition in the treatment of chronic uremia, in Nutrition in Renal Disease, edited by Berlyne GM, Baltimore, Williams and Wilkins, 1968, p 23Google Scholar
  48. 48.
    Kopple JD, Swendseid ME, Shinaberger JH, Umezawa CY: The free and bound amino acids removed by hemodialysis. Trans Am Soc Artif Intern Organs 19: 309, 1973PubMedGoogle Scholar
  49. 49.
    Ikizler TA, Flakoll PJ, Parker RA, Hakim RM: Amino acid and albumin losses during hemodialysis. Kidney Int 46: 830, 1994PubMedGoogle Scholar
  50. 50.
    Wolfson M, Jones MR, Kopple JD: Amino acid losses during hemodialysis with infusion of amino acids and glucose. Kidney Int 21: 500, 1982PubMedGoogle Scholar
  51. 51.
    Wathen RL, Keshaviah P, Hommeyer P, Caldwell K, Comty CM: The metabolic effects of hemodialysis with and without glucose in the dialysate. Am J Clin Nutr 31: 1870, 1978PubMedGoogle Scholar
  52. 52.
    Gutierrez A, Bergstrom J, Alvestrand A: Hemodialysis-associated protein catabolism with and without glucose in the dialysis fluid. Kidney: Int 46: 814, 1994Google Scholar
  53. 53.
    Levin NW: Dialyzer reuse. A currently acceptable practice. Semin Dial 6: 89, 1993Google Scholar
  54. 54.
    Kaplan AA, Halley SE, Lapkin RA, Graeber CW: Dialysate protein losses with bleach processed polysulphone dialyzers. Kidney Int 47: 573, 1995PubMedGoogle Scholar
  55. 55.
    Giordano C, DeSanto NG, Capodicasa G et al.: Amino acid losses during CAPD. Clin Nephrol 14: 230, 1980PubMedGoogle Scholar
  56. 56.
    Kopple JD, Blumenkrantz MJ. Jones MR, Moran JK, Coburn JW: Plasma amino acid levels and amino acid losses during continuous ambulatory peritoneal dialysis. Am J Clin Nutr 36: 395, 1982PubMedGoogle Scholar
  57. 57.
    Blumenkrantz MJ, Gahl GM, Kopple JD et al.: Protein losses during peritoneal dialysis. Kindney Int 19: 593, 1981Google Scholar
  58. 58.
    Andersen KEH: Folic acid status of patients with chronic renal failure maintained by dialysis. Clin Nephrol 8: 510, 1977Google Scholar
  59. 59.
    Rostand SG: Vitamin B12 levels and nerve conduction velocities in patients undergoing maintenance hemodialysis. Am J Clin Nutr 29: 691, 1976PubMedGoogle Scholar
  60. 60.
    Sullivan JF, Eisenstein AB, Mottola OM, Mittal AK: The effect of dialysis on plasma and tissue levels of vitamin C. Trans Am Soc Artif Intern Organs 18: 277, 1972PubMedGoogle Scholar
  61. 61.
    Linton AL, Clark WF, Dreidger AA, Werb R, Lindsay RM: Correctable factors contributing to the anemia of dialysis patients. Nephron 19: 95, 1977PubMedGoogle Scholar
  62. 62.
    Rosenblatt SG, Drake S, Fadem S, Welch R, Lifschitz MD: Gastrointestinal blood loss in patients with chronic renal failure. Am J Kidney Dis 1: 232, 1982PubMedGoogle Scholar
  63. 63.
    De Fronzo RA, Tobin JD, Rowe JW, Andres R: Glucose intolerance in uremia: quantification of pancreatic beta cell sensitivity to glucose and tissue sensitivity to insulin. J Clin Invest 62: 425, 1978Google Scholar
  64. 64.
    Fouque D: Insulin-like growth factor-1 (IGF-1) resistance in renal failure. Miner Electrolyte Metab 1995. In pressGoogle Scholar
  65. 65.
    Kuku SF, Zeidler A, Emmanouel DS, Ratz AI, Rubenstein AH: Heterogeneity of plasma glucagon: patterns in patients with chronic renal failure and diabetes. J Clin Endocrinol Metab 42: 173, 1976PubMedCrossRefGoogle Scholar
  66. 66.
    Fouque D, Peng S, Kopple JD: Impaired metabolic response to recombinant human insulin-like growth factor-1 in dialysis patients. Kidney Int 47: 876, 1995PubMedGoogle Scholar
  67. 67.
    Birge SJ, Haddad JG: 25-hydroxycholecalciferol stimulation of muscle metabolism. J Clin Invest 56: 1100, 1974Google Scholar
  68. 68.
    May RC, Kelly RA, Mitch WE: Mechanisms for defects in muscle protein metabolism in rats with chronic uremia. J Clin Invest 79: 1099, 1987PubMedGoogle Scholar
  69. 69.
    Mitch WE, May RC, Maroni BJ, Druml W: Protein and amino acid metabolism in uremia: influence of metabolic acidosis. Kidney Int 36(Suppl 27): S205, 1989Google Scholar
  70. 70.
    Reaich D, Channon S, Scrisgeour CM, Daley SE, Wilkinson R, Goodship THJ: Correction of acidosis in humans with CRF decreases protein degradation and amino acid oxidation. Am J Physiol 265: E230, 1993PubMedGoogle Scholar
  71. 71.
    Raine AEG, Bedford L, Simpson AWM et al.: Hyperparathyroidism, platelet intracellular free calcium and hypertension in chronic renal failure. Kidney Int 43: 700, 1993PubMedGoogle Scholar
  72. 72.
    Akmal M, Massry SG, Goldstein DA, Fanti F, Weisz A, DeFronzo RA: Role of parathyroid hormone in the glucose intolerance of chronic renal failure. J Clin Invest 75: 1037, 1985PubMedGoogle Scholar
  73. 73.
    Akmal M, Barndt RR, Ansari AN, Mohler JG, Massry SG: Excess PTH in CRF induces pulmonary calcification, pulmonary hypertension and right ventricular hypertrophy. Kidney Int 47: 158, 1995PubMedGoogle Scholar
  74. 74.
    Gao XL, Kopple JD: Relationship between dietary protein, urea nitrogen appearance (UNA) and total nitrogen appearance (TNA) in patients with chronic renal failure. (Abstract) J Am Soc Nephrol 5: 491, 1994Google Scholar
  75. 75.
    Karvetti RL, Knuts LR: Validity of the estimated food diary: comparison of 2-day recorded and observed food and nutrient intakes. J Am Diet Assoc 92: 580, 1992PubMedGoogle Scholar
  76. 76.
    Daugirdas JT: Second generation logarithmic estimates of single-pool variable volume ST/V: an analysis of error. J Am Soc Nephrol 4: 1205, 1993PubMedGoogle Scholar
  77. 77.
    Poignet JL, Chauveau P, Desassis JF, Puget J: Adequacy of hemodialysis and nutrition: evaluation of an on-line urea monitor. (Abstract) J Am Soc Nephrol 5: 525, 1994Google Scholar
  78. 78.
    Blumenkrantz MJ, Kopple JD, Moran JK, Grodstein GP, Coburn JW: Nitrogen and urea metabolism during continuous ambulatory peritoneal dialysis. Kidney Int 20: 78, 1981PubMedGoogle Scholar
  79. 79.
    Bergström J, Furst P, Alvestrand A, Lindholm B: Protein and energy intake, nitrogen balance and nitrogen losses in patients treated with continuous ambulatory peritoneal dialysis. Kidney Int 44: 10481, 1993Google Scholar
  80. 80.
    Keshaviah PR, Nolph KD, Moore HL et al.: Lean body mass estimation by creatinine kinetics. J Am Soc Nephrol 4: 1475, 1994PubMedGoogle Scholar
  81. 81.
    Walser M: Creatinine excretion as a measure of protein nutrition in adults of varying age. J Parenter Enteral Nutr 11: 573, 1987CrossRefGoogle Scholar
  82. 82.
    Blagg CR, Liedtke RL, Batjer JD et al.: Serum albumin concentration-related health care financing administration quality assurance criterion is method-dependent: revision is necessary. Am J Kidney Dis 21: 138, 1993PubMedGoogle Scholar
  83. 83.
    Cano N, DiCostanzo-Dufetel J. Calaf K et al.: Prealbumin-retinol-binding-protein-retinol complex in hemodialysis patients. Am J Clin Nutr 47: 664, 1988PubMedGoogle Scholar
  84. 84.
    Cano N, Stroumza P, Lacombe P, Labastie-Coeyrehourcq J, Durbec JP: Serum transthyretin and protein intake in haemodialysis patients. (Letter) Nephrol Dial Transplant 7: 1069, 1992PubMedGoogle Scholar
  85. 85.
    Cano N, Stroumza P, Lacombe P, Labastie-Coeyrehourcq J: Plasma prealbumin in hemodialysis patients. (Letter) Am J Kidney Dis 23: 621, 1994PubMedGoogle Scholar
  86. 86.
    Goldwasser P, Michel MA, Collier J et al.: Prealbumin and lipoprotein(a) in hemodialysis: relationships with patient and vascular access survival. Am J Kidney Dis 22: 215, 1993PubMedGoogle Scholar
  87. 87.
    Hakim RM, Levin N: Malnutrition in hemodialysis patients. Am J Kidney Dis 21: 125, 1993PubMedGoogle Scholar
  88. 88.
    Lukaski HC, Mendez J, Buskirk ER, Cohn SH: Relationship between endogenous 3-methylhistidine excretion and body composition. Am J Physiol 240: E302, 1981PubMedGoogle Scholar
  89. 89.
    Thomas AE, McKay DA, Cutlip MB: A nomograph method for assessing body weight. Am J Clin Nutr 29: 302, 1976PubMedGoogle Scholar
  90. 90.
    Heymsfield SB: Assessment of body composition. American Society for Parenteral and Enteral Nutrition annual meeting, San Diego, 1993, p 179Google Scholar
  91. 91.
    Smalley KJ, Knerr AK, Kendrick ZV, Colliver JA, Owen OE: Reassessment of body mass indices. Am J Clin Nutr 52: 405, 1990PubMedGoogle Scholar
  92. 92.
    Frisancho AR: New standards of weight and body composition by frame size and height for assessment of nutritional status of adults and the elderly. Am J Clin Nutr 40: 808, 1984PubMedGoogle Scholar
  93. 93. 1983 Metropolitan height and weight tables. Statistical Bull Metrop Insur Co 64: 3, 1983Google Scholar
  94. 94.
    Durnin JV, Womersley J: Body fat assessed from total body density and its estimation from skinfold thickness; measurements on 481 men and women aged from 16 to 72 years. Br J Nutr 32: 77, 1974PubMedGoogle Scholar
  95. 95.
    Blumenkrantz MJ, Kopple JD, Gutman RA et al.: Methods for assessing nutritional status of patients with renal failure. Am J Clin Nutr 33: 1567, 1980PubMedGoogle Scholar
  96. 96.
    Lukaski HC, Bolonchuk WW, Hall CB, Siders WA: Validation of tetrapolar bioelectrical impedance methods to assess human body composition. J Appl Physiol 60: 1327, 1986PubMedGoogle Scholar
  97. 97.
    Deurenberg P, Weststrate JA, Hautvast JGAJ: Changes in fat-free mass during weight loss measured by bioelectrical impedance and by densitometry. Am J Clin Nutr 49: 33, 1989PubMedGoogle Scholar
  98. 98.
    Charney DI, Leypoldt JK, Chan GM: Validity of dual-energy X-ray absorptiometry (DEXA) and single frequency bioelectrical impedance analysis (BIA) in chronic hemodialysis patients. (Abstract) J Am Soc Nephrol 4: 339, 1993Google Scholar
  99. 99.
    Dumler F, Schmidt R, Kilates C, Faber M, Lubkowski T, Frinak S: Use of bioelectrical impedance for the nutritional assessment of chronic hemodialysis patients. Miner Electrolyte Metab 18: 284, 1992PubMedGoogle Scholar
  100. 100.
    Spotti D, Librenti MC, Melandri M et al.: Bioelectrical impedance in the evaluation of the nutritional status of hemodialyzed diabetic patients. Clin Nephrol 39: 172, 1993PubMedGoogle Scholar
  101. 101.
    Wang J, Pierson RN, Kelly WG: A rapid method for the determination of deuterium oxide in man: application to the measurement of total body water. J Lab Clin Med 82: 170, 1983Google Scholar
  102. 102.
    Heymsfield SB, Wang J, Funfar J, Kehayias JJ, Pierson RN: Dual photon absorptiometry. Comparison of bone mineral and soft tissue mass measurement in vivo with established methods. Am J Clin Nutr 49: 1283, 1989PubMedGoogle Scholar
  103. 103.
    Going SB, Massett MP, Hall MC et al.: Detection of small changes in body composition by dual-energy X-ray absorptiometry. Am J Clin Nutr 57: 845, 1993PubMedGoogle Scholar
  104. 104.
    Roubenoff R, Kehayias JJ, Dawson-Hughes B, Heymsfield SB: Use of dual-energy x-ray absorptiometry in body-composition studies: not yet a ‘gold standard’. Am J Clin Nutr 58: 589, 1993PubMedGoogle Scholar
  105. 105.
    Ross R, Leger L, Morris D, de Guise J, Guardo R: Quantification of adipose tissue by MRI: relationship with anthropometric variables. J Appl Physiol 72: 787, 1992PubMedGoogle Scholar
  106. 106.
    Brummer RJM, Rosen T, Bengtsson BA: Evaluation of different methods of determining body composition, with special reference to growth hormone-related disorders. Acta Endocrinol 128(Suppl 2): 30, 1993PubMedGoogle Scholar
  107. 107.
    Sohlstrom A, Wahlund LO, Forsum E: Adipose tissue distribution as assessed by magnetic resonance imaging and total body fat by magnetic resonance imaging, underwater weighing, and body-water dilution in healthy women. Am J Clin Nutr 58: 830, 1993PubMedGoogle Scholar
  108. 108.
    Baker JP, Detsky AS, Wesson DE et al.: Nutritional assessment: a comparison of clinical judgement and objective measurements. N Engl J Med 306: 969, 1982PubMedCrossRefGoogle Scholar
  109. 109.
    Detsky AS, McLaughlin JR, Baker JP et al.: What is subjective global assessment of nutritional status? J Parenter Enteral Nutr 11: 8, 1987Google Scholar
  110. 110.
    Enia G, Sicuso C, Alati G, Zoccali C: Subjective global assessment of nutritional in dialysis patients. Nephrol Dial Transplant 8: 1094, 1993PubMedGoogle Scholar
  111. 111.
    Monteon FJ, Laidlaw SA, Shaib JR, Kopple JD: Energy expenditure in patients with chronic renal failure. Kidney Int 30: 741, 1986PubMedGoogle Scholar
  112. 112.
    Schneeweiss B, Graninger W, Stockenhuber F et al.: Energy metabolism in acute and chronic renal failure. Am J Clin Nutr 52: 596, 1990PubMedGoogle Scholar
  113. 113.
    Slomowitz LA, Monteon FJ, Grosvenor M, Laidlaw SA, Kopple JD: Effect of energy intake on nutritional status in maintenance hemodialysis patients. Kidney Int 35: 704, 1989PubMedGoogle Scholar
  114. 114. Recommended Dietary Allowances. National Academy Press, 10th Edition, Washington DC, 1989Google Scholar
  115. 115.
    Guttierez A, Bergström J, Alvestrand A: Hemodialysis-associated protein catabolism with and without glucose in the dialysis fluid. Kidney Int 46: 814, 1994Google Scholar
  116. 116.
    Blumenkrantz MJ, Kopple JD, Moran JK, Coburn JW: Metabolic studies and dietary protein requirements in patients undergoing continuous ambulatory peritoneal dialysis. Kidney Int 21: 849, 1982PubMedGoogle Scholar
  117. 117.
    De Fronzo RA: Hyperkalemia and hyporeninemic hypoaldosteronism. Kidney Int 17: 118, 1980Google Scholar
  118. 118.
    Kopple JD, Coburn JW: Metabolic studies of low protein diets in uremia. II. Calcium, phosphorus and magnesium. Medicine 52: 597, 1973PubMedGoogle Scholar
  119. 119.
    Randall RE Jr, Cohen MD, Spray CC Jr et al.: Hyper-magnesemia in renal failure: etiology and toxic manifestations. Ann Intern Med 61: 73, 1964PubMedGoogle Scholar
  120. 120.
    Wallach S: Effects of magnesium on skeletal metabolism. Magnes Trace Elem 9: 1, 1990PubMedGoogle Scholar
  121. 121.
    Rabinowitz MB, Kopple JD, Wetherill GW: Effect of food intake and fasting on gastrointestinal lead absorption in humans. Am J Clin Nutr 33: 1784, 1980PubMedGoogle Scholar
  122. 122.
    Toback FG: Amino acid treatment of acute renal failure. in Acute Renal Failure, edited by Brenner BM, Stein JH, London, Churchill Livingstone, 1980, p 202Google Scholar
  123. 123.
    Sullivan JF, Eisenstein AB: Ascorbic acid depletion during hemodialysis. JAMA 220: 1697, 1972PubMedGoogle Scholar
  124. 124.
    Whitehead VM, Comty CH, Posen GA, Kaye M: Homeostasis of folic acid in patients undergoing maintenance hemodialysis. N Engl J Med 279: 970, 1968PubMedCrossRefGoogle Scholar
  125. 125.
    Sullivan JF, Eisenstein AB: Ascorbic acid depletion in patients undergoing chronic hemodialysis. Am J Clin Nutr 23: 1339, 1970PubMedGoogle Scholar
  126. 126.
    Descombes E, Hanck AB, Fellay G: Water soluble vitamins in chronic hemodialysis patients and need for supplementation. Kidney Int 43: 1319, 1993PubMedGoogle Scholar
  127. 127.
    Dobbelstein H, Korner WF, Mempel W, Grosse-Wilde H, Edel HH: Vitamin B6 deficiency in uremia and its implications for the depression of immune responses. Kidney Int 5: 233, 1974PubMedGoogle Scholar
  128. 128.
    Kopple JD, Mercurio K, Blumenkrantz MJ et al.: Daily requirement for pyridoxine supplements in chronic renal failure. Kidney Int 19: 694, 1981PubMedGoogle Scholar
  129. 129.
    Casciato DA, McAdam LP, Kopple JD et al.: Immunologic abnormalities in hemodialysis patients: improvement after pyridoxine therapy. Nephron 38: 9, 1984PubMedGoogle Scholar
  130. 130.
    Yatzidis H, Digenis P, Fountas P: Hypervitaminosis A accompanying advanced chronic renal failure. Br Med J 2: 352, 1975Google Scholar
  131. 131.
    Padovese P, Gallieni M, Brancaccio D et al.: Trace elements in dialysis fluids and assessment of the exposure of patients on regular hemodialysis, hemofiltration and continuous ambulatory peritoneal dialysis. Nephron 61: 442, 1992PubMedGoogle Scholar
  132. 132.
    Atkin-Thor E, Goddard BW, O’Nion J, Stephen RL, Kolff WJ: Hypogeusia and zinc depletion in chronic dialysis patients. Am J Clin Nutr 31: 1948, 1978PubMedGoogle Scholar
  133. 133.
    Mahajan SK, Bowersox EM, Rye DL et al.: Factors underlying abnormal zinc metabolism in uremia. Kidney Int 36(Suppl 27): S269, 1989Google Scholar
  134. 134.
    Antoniou LD, Shalhoub RJ, Sudhakar T. Smith JC: Reversal of uremic impotence by zinc. Lancet ii: 895, 1977Google Scholar
  135. 135.
    Rodger RS, Sheldon WL, Watson MJ et al.: Zinc deficiency and hyperprolactinemia are not reversible causes of sexual dysfunction in uremia. Nephrol Dial Transplant 4: 888, 1989PubMedGoogle Scholar
  136. 136.
    Kallistratos G, Evangelou A, Seferiadis K, Vezyraki P, Barboutis K: Selenium and haemodialysis: serum selenium levels in healthy persons, noncancer and cancer patients with chronic renal failure. Nephron 41: 217, 1985PubMedGoogle Scholar
  137. 137.
    Cornells R, Mees L, Ringoir S, Hoste J: Serum and red blood cell Zn, Se, Cs, and Rb in dialysis patients. Miner Electrolyte Metab 2: 88, 1979Google Scholar
  138. 138.
    Milly K, Wit L, Diskin C, Tulley R: Selenium in renal failure patients. Nephron 61: 139, 1992PubMedGoogle Scholar
  139. 139.
    Golper TA: Severe malnutrition II. Semin Dial 6: 362, 1993Google Scholar
  140. 140.
    Wolfson M: The cost and bother of intradialytic parenteral nutrition are not justified by available scientific studies. ASA1O J 39: 864, 1993Google Scholar
  141. 141.
    Wolfson M: Use of intradialytic parenteral nutrition in hemodialysis patients. Am J Kidney Dis 23: 856, 1994PubMedGoogle Scholar
  142. 142.
    Cano N, Labastie-Coeyrehourcq J, Lacombe P et al.: Perdialytic parenteral nutrition with lipids and amino acids in malnourished hemodialysis patients. Am J Clin Nutr 52: 726, 1990PubMedGoogle Scholar
  143. 143.
    Lacour B, Roullet JB, Drueke T: Les perturbations du métabolisme lipidique dans l’insuffisance rénale chronique. Néphrologie 4: 75, 1983PubMedGoogle Scholar
  144. 144.
    Cano N, Luc G, Stroumza P, Lacombe P, Durbec JP: Serum lipoprotein changes after prolonged intralipid infusion in malnourished haemodialysis patients. Clin Nutr 13: 111, 1994PubMedGoogle Scholar
  145. 145.
    Kopple JD, Bernard D, Messana J et al.: Treatment of malnourished CAPD patients with an amino acid based dialysate. Kidney Int47: 1148, 1995PubMedGoogle Scholar
  146. 146.
    Chertow GM, Ling J, Lew NL, Lazarus JM, Lowrie EG: The association of intradialytic parenteral nutrition administration with survival in hemodialysis patients. Am J Kidney Dis 24: 912, 1994PubMedGoogle Scholar
  147. 147.
    Capelli JP, Kushner H, Camiscioli TC, Chen SM, Torres MA: Effect of intradialytic parenteral nutrition on mortality rates in end-stage renal disease care. Am J Kidney Dis 23: 808, 1994PubMedGoogle Scholar
  148. 148.
    Gupta BK, Plotner E, Spinowitz BS, Charytan C: Severe malnutrition IV. Semin Dial 6: 366, 1993Google Scholar
  149. 149.
    Cano N: Nutrition entérale et parentérale chez l’insuffisant rénal chronique hémodialysé. Nutr Clin Métabol 8: 205, 1994Google Scholar
  150. 150.
    Schulman G, Wingard RL, Hutchinson RL, Lawrence P, Hakim RM: The effects of recombinant human growth hormone and intradialytic parenteral nutrition in malnourished hemodialysis patients. Am J Kidney Dis 21: 527, 1993PubMedGoogle Scholar
  151. 151.
    Peng S, Fouque D, Kopple JD: Insulin-like growth factor 1 (IGF-1) causes anabolism in malnourished CAPD patients. (Abstract) J Am Soc Nephrol 3: 414, 1993Google Scholar

Copyright information

© Kluwer Academic Publishers 1996

Authors and Affiliations

  • Denis Fouque
    • 1
  • Joel D. Kopple
    • 2
  1. 1.Department of Nephrology Hôpital Edouard HerriotUniversity Claude BernardLyon Cédex 03France
  2. 2.Harbor-UCLA Medical CenterTorranceUSA

Personalised recommendations